Literature DB >> 3020025

Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia.

H H Hobbs, M S Brown, J L Goldstein, D W Russell.   

Abstract

The proposed ligand binding domain of the low density lipoprotein (LDL) receptor consists of a 40-amino acid cysteine-rich unit that is repeated with some variation seven times. We describe here a mutant allele at the LDL receptor locus in which one of the seven repeats has been deleted. This mutation was found in a patient with the clinical syndrome of homozygous familial hypercholesterolemia. By molecular cloning, we show that the deletion arose by homologous recombination between repetitive Alu sequences in intron 4 and intron 5 of the gene. The deletion removes exon 5, which normally encodes the sixth repeat of the ligand binding domain. In the resultant mRNA, exon 4 is spliced to exon 6, preserving the reading frame. This mRNA produces a shortened protein that reaches the cell surface and reacts with anti-receptor antibodies but does not bind LDL, which contains apoprotein B-100 as its major protein component. Surprisingly, the deleted protein retains the ability to bind and internalize beta-migrating very low density lipoprotein, a lipoprotein that contains apoprotein E as well as apoprotein B-100. These data support the hypothesis that the seven repeated sequences in the receptor constitute the LDL binding domain. The data further indicate that the sixth repeat is required for binding of LDL, but not beta-migrating very low density lipoprotein, and that deletion of a single cysteine-rich repeat can alter the binding specificity of the LDL receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020025

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Cloning, sequencing, and analysis of inv8 chromosome breakpoints associated with recombinant 8 syndrome.

Authors:  S L Graw; T Sample; J Bleskan; E Sujansky; D Patterson
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  The Lebanese allele at the LDLR in normocholesterolemic people merits reconsideration of genotype phenotype correlations in familial hypercholesterolemia.

Authors:  Akl C Fahed; Fadi F Bitar; Ruby I Khalaf; Elie M Moubarak; Sami T Azar; Georges M Nemer
Journal:  Endocrine       Date:  2012-04-10       Impact factor: 3.633

3.  Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.

Authors:  D C Rubinsztein; J C Cohen; G M Berger; D R van der Westhuyzen; G A Coetzee; W Gevers
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.

Authors:  M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

5.  Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance.

Authors:  F Shimada; Y Suzuki; M Taira; N Hashimoto; O Nozaki; H Makino; S Yoshida
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

6.  Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.

Authors:  C Lackner; E Boerwinkle; C C Leffert; T Rahmig; H H Hobbs
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

7.  Differential regulation of Na/H antiporter by acid in renal epithelial cells and fibroblasts.

Authors:  O W Moe; R T Miller; S Horie; A Cano; P A Preisig; R J Alpern
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Phenotypic and genetic variation in leptin as determinants of weight regain.

Authors:  G Erez; A Tirosh; A Rudich; V Meiner; D Schwarzfuchs; N Sharon; S Shpitzen; M Blüher; M Stumvoll; J Thiery; G M Fiedler; Y Friedlander; E Leiterstdorf; I Shai
Journal:  Int J Obes (Lond)       Date:  2010-11-02       Impact factor: 5.095

9.  Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.

Authors:  E Leitersdorf; H H Hobbs; A M Fourie; M Jacobs; D R van der Westhuyzen; G A Coetzee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Prenatal diagnosis of familial hypercholesterolemia caused by the "Lebanese" mutation at the low density lipoprotein receptor locus.

Authors:  A Reshef; V Meiner; E J Dann; M Granat; E Leitersdorf
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.